J-Frontier revised its consolidated earnings forecast for the fiscal year ending May 2026, lowering projected sales to 22,235 million yen, and plans to record a goodwill amortization expense of 435 million yen as a special loss. Net profit is expected to fall short of the previous forecast.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2934","jir_company_name":"J-Frontier Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/2934-20260714-01.pdf","jir_short_summary":"J-Frontier revised its consolidated earnings forecast for the fiscal year ending May 2026, lowering projected sales to 22,235 million yen, and plans to record a goodwill amortization expense of 435 million yen as a special loss. Net profit is expected to fall short of the previous forecast.","jir_summary":"### Overview of Business Results\nJ-Frontier has revised its consolidated earnings forecast for the fiscal year ending May 2026, lowering sales to 22,235 million yen. Although sales are expected to fall below the previous forecast due to a strategic focus on advertising efficiency and new customer acquisition, EBITDA and operating profit are expected to be largely in line with expectations. Ordinary income is anticipated to exceed previous forecasts due to increased gains and losses on financial securities. However, net income attributable to owners of the parent is expected to fall below previous forecasts due to the recording of a goodwill amortization as a special loss.\n\n### Future Outlook and Impact on Shareholders\nThe revision lowered the outlook for sales and net income, but ordinary income is expected to increase. The recording of a goodwill amortization as a special loss is a temporary measure, and it is thought that it will have a limited impact on future business prospects. For investors, the slowdown in sales growth may necessitate reviews of cost structures and strategic reevaluations.","jir_financial_highlights":"Sales: 22,235 million yen (\u25b31,364 million yen (\u25b35.8%))\nOperating profit: 312 million yen (\u25b314 million yen (\u25b34.5%))\nNet income attributable to owners of the parent: \u25b3321 million yen (Unknown change (expected to fall below previous forecast))","jir_category":"","jir_hashtags":"#J-Frontier, #EarningsRevision, #JapaneseStocks","jir_key_figures":"Sales: 22,235 million yen (down 5.8% YoY)\nOperating profit: 312 million yen (down 4.5% YoY)\nNet income attributable to owners of the parent: \u25b3321 million yen (with a goodwill amortization expense of 435 million yen recorded as a special loss)","jir_meta_title":"\u3010J-Frontier\u3011FY2026 Earnings Revision | Lowered to 22,235 billion yen in sales","jir_meta_description":"J-Frontier revised its earnings forecast for FY ending May 2026, lowering sales to 22,235 million yen. It also reports extraordinary losses and outlook for net profit.","jir_og_title":"\u3010J-Frontier\u3011FY2026 Earnings Revision | Sales of 22,235 billion yen","jir_og_description":"J-Frontier revised its earnings outlook for FY ending May 2026 downward and recorded extraordinary losses. Provides key information for investment decisions.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Sales Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"June 2025\\\",\\\"July 2025\\\",\\\"August 2025\\\",\\\"September 2025\\\",\\\"October 2025\\\"],\\\"datasets\\\": [{\\\"label\\\": \\\"Sales\\\",\\\"data\\\": [Unknown, Unknown, Unknown, Unknown, Unknown],\\\"borderColor\\\": \\\"#36A2EB\\\",\\\"fill\\\": false}]}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Profit Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"June 2025\\\",\\\"July 2025\\\",\\\"August 2025\\\",\\\"September 2025\\\",\\\"October 2025\\\"],\\\"datasets\\\": [{\\\"label\\\": \\\"Operating Profit\\\",\\\"data\\\": [Unknown, Unknown, Unknown, Unknown, Unknown],\\\"borderColor\\\": \\\"#FF6384\\\",\\\"fill\\\": false}]}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"pie\", \"jir_chart_title\": \"Segment-wise Revenue Composition\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"Medical Care\\\",\\\"Healthcare\\\",\\\"Others\\\"],\\\"datasets\\\": [{\\\"data\\\": [Unknown, Unknown, Unknown],\\\"backgroundColor\\\": [\\\"#FF6384\\\",\\\"#36A2EB\\\",\\\"#FFCE56\\\"]}]}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Profit Margin Analysis\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"Sales\\\",\\\"Operating Profit\\\",\\\"Net Profit\\\"],\\\"datasets\\\": [{\\\"label\\\": \\\"June 2025\\\",\\\"data\\\": [Unknown, Unknown, Unknown],\\\"backgroundColor\\\": [\\\"#4BC0C0\\\",\\\"#FF6384\\\",\\\"#36A2EB\\\"]}]} \"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Comparison of Forecasts and Actuals\", \"jir_chart_json_data\": \"{\\\"columns\\\": [\\\"Item\\\",\\\"Previous Forecast\\\",\\\"Revised Forecast\\\"],\\\"rows\\\": [[\\\"Sales\\\",\\\"23,600 million yen\\\",\\\"22,235 million yen\\\"],[\\\"Operating Profit\\\",\\\"1,015 million yen\\\",\\\"312 million yen\\\"],[\\\"Net Profit attributable to Owners of the Parent\\\",\\\"100 million yen\\\",\\\"\u25b3321 million yen\\\"]]}\"}]","ir_related_company":59459,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-80154","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n